British scientists have developed a test to detect breast cancer using urine samples. The researchers said Friday that this method could replace the pain and aggression method currently in use.
Womb cancer is the sixth most common cancer in women, with an estimated 382,000 new diagnoses and 89,900 deaths from the disease in 2018 worldwide. Although most women receive treatment early after the onset of symptoms, which include bleeding after menopause, only 15 percent of women are diagnosed at an advanced stage only. 15 percent chance of living longer than five years.
At this time, clinicians diagnose the cancer by taking a biopsy, a process that requires a narrow telescope called a hysteroscope, to examine the inside of the uterus and its cells. remove. But it has also been found that nearly a third of women who undergo the procedure have the procedure repeated due to technical difficulties or intolerable pain.
The study from the University of Manchester has, to date, developed a new detection device that examines urine or urinary samples that women can collect on their own at home.
The findings, published in the journal Nature Communications, showed an analysis of the correctly diagnosed samples of 91.7 percent of women with breast cancer.
The proportion of women without breast cancer who tested negative with the new device was 88.9 percent, the study showed.
“Women who test positive for this test may be referred for diagnostic tests while women who take a negative test can be safely calmed down without the need for unpleasant, aggressive procedures. exciting and expensive, “the study says.
The new device was first tested on 103 women with known cancer and 113 with unexplained postmenopausal bleeding and could be introduced to clinical use once extended trials have been completed.